var data={"title":"Inosine pranobex (United States: Not available): Drug information","body":"<div id=\"topicContent\" class=\"utdArticleSection utdStyle\"><div id=\"drugTitle\">Inosine pranobex (United States: Not available): Drug information</div><div id=\"lexiTitleImg\"></div><div class=\"clear\"></div><div id=\"lcoSearchClickUrl\"><a href=\"http://online.lexi.com/lco/action/api/find/globalid/44100?utd=1\" target=\"_blank\">Access Lexicomp Online here.</a></div><div id=\"drugCopy\">Copyright 1978-2018 Lexicomp, Inc. All rights reserved.</div><div id=\"topicText\">(For additional information <a href=\"topic.htm?path=inosine-pranobex-united-states-not-available-patient-drug-information\" class=\"drug drug_patient\">see &quot;Inosine pranobex (United States: Not available): Patient drug information&quot;</a>)<br></br>For abbreviations and symbols that may be used in Lexicomp (<a href=\"image.htm?imageKey=DRUG%2F57469\" class=\"graphic graphic_table\">show table</a>)<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F16144138\" class=\"list cbnlist drugH1Div drugBrandNames\"><span class=\"drugH1\">Brand Names: Canada</span>\n    <ul>\n      <li>Imunovir&reg;</li></ul></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F16222941\" class=\"ex_sect_xr thclist drugH1Div drugBrandNames\"><span class=\"drugH1\">Pharmacologic Category</span>\n    <ul>\n      <li>\n        Antiviral Agent;</li>\n      <li>\n        Immunomodulator, Systemic</li></ul></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F16222976\" class=\"block doa drugH1Div\"><span class=\"drugH1\">Dosing: Adult</span>\n    <p style=\"text-indent:0em;display:inline\">\n      <b>Subacute sclerosing panencephalitis (SSPE):</b> Oral: 50 mg/kg/day in 3-4 equally divided doses (maximum: 3 g daily)</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F50990268\" class=\"block dora drugH1Div\"><span class=\"drugH1\">Dosing: Renal Impairment (Adult)</span>\n    <p style=\"text-indent:0em;display:inline\">There is no dosage adjustment provided in manufacturer&rsquo;s labeling.</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F50987470\" class=\"block doha drugH1Div\"><span class=\"drugH1\">Dosing: Hepatic Impairment (Adult)</span>\n    <p style=\"text-indent:0em;display:inline\">There is no dosage adjustment provided in manufacturer&rsquo;s labeling.</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F16222975\" class=\"block dop drugH1Div\"><span class=\"drugH1\">Dosing: Pediatric</span>\n    <p style=\"text-indent:0em;display:inline\">\n      <b>Subacute sclerosing panencephalitis (SSPE):</b> Refer to adult dosing.</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F51159582\" class=\"block dorp drugH1Div\"><span class=\"drugH1\">Dosing: Renal Impairment (Pediatric)</span>\n    <p style=\"text-indent:0em;display:inline\">There is no dosage adjustment provided in manufacturer&rsquo;s labeling.</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F51159583\" class=\"block dohp drugH1Div\"><span class=\"drugH1\">Dosing: Hepatic Impairment (Pediatric)</span>\n    <p style=\"text-indent:0em;display:inline\">There is no dosage adjustment provided in manufacturer&rsquo;s labeling.</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F16222977\" class=\"block doe drugH1Div\"><span class=\"drugH1\">Dosing: Geriatric</span>\n    <p style=\"text-indent:0em;display:inline\">Refer to adult dosing.</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F16222986\" class=\"block foccan drugH1Div\"><span class=\"drugH1\">Dosage Forms: Canada</span>\n    <p style=\"text-indent:0em;display:inline\">Information with regard to form, strength, and availability of products uniquely available in Canada but currently not available in the US.</p>\n    <p style=\"text-indent:-2em;margin-left:2em;margin-top:2em;\">Excipient information presented when available (limited, particularly for generics); consult specific product labeling.</p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Tablet, oral:</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">Imunovir&reg;: 500 mg</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F16222985\" class=\"block prod-avail drugH1Div\"><span class=\"drugH1\">Product Availability</span>\n    <p style=\"text-indent:0em;display:inline\">Not available in the US</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F16222980\" class=\"block adm drugH1Div\"><span class=\"drugH1\">Administration</span>\n    <p style=\"text-indent:0em;display:inline\">Administer orally in 3-4 equally divided doses while awake.</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F16144139\" class=\"block use drugH1Div\"><span class=\"drugH1\">Use</span>\n    <p style=\"text-indent:0em;display:inline\">\n      <b>Note:</b> Not approved in the US</p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Treatment of slowly progressive subacute sclerosing panencephalitis (SSPE); may delay neurologic deterioration and prolong life expectancy </p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F16222949\" class=\"block adr drugH1Div\"><span class=\"drugH1\">Adverse Reactions</span>\n    <p style=\"text-indent:0em;display:inline\">Frequency not defined.</p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Central nervous system: Dizziness, fatigue, headache, insomnia, nervousness</p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Dermatologic: Pruritus, skin rash</p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Endocrine &amp; metabolic: Hyperuricemia</p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Gastrointestinal: Constipation, diarrhea, gastric distress</p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Genitourinary: Increased urine output</p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Neuromuscular &amp; skeletal: Arthralgia</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F16222945\" class=\"block coi drugH1Div\"><span class=\"drugH1\">Contraindications</span>\n    <p style=\"text-indent:0em;display:inline\">There are no contraindications listed in the manufacturer&rsquo;s product monograph.</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F16222946\" class=\"block war drugH1Div\"><span class=\"drugH1\">Warnings/Precautions</span>\n    <p style=\"text-indent:-2em;margin-left:2em;\">\n      <b>\n        <i>Concerns related to adverse effects:</i></b></p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">&bull; Uric acid: Inosine undergoes rapid metabolism to uric acid. Use with caution in patients with a history of gout, urolithiasis, nephrolithiasis, or renal impairment. Uricosuric agents (eg, probenecid) or antihyperuricemic therapy (eg, allopurinol) may be necessary for extremely elevated serum uric acid levels.</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F16265510\" class=\"block cyt drugH1Div\"><span class=\"drugH1\">Metabolism/Transport Effects</span>\n    <p style=\"text-indent:0em;display:inline\">None known.</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F16265508\" class=\"block dri drugH1Div\"><span class=\"drugH1\">Drug Interactions</span>\n    <br/><br/><div id=\"lexiInteractAddInfo\" class=\"lexi\">(For additional information: <a href=\"https://www.uptodate.com/drug-interactions/?search=&amp;topicId=88326&amp;source=responsive_topic\" class=\"dip\" target=\"_blank\">Launch drug interactions program</a>)</div><div id=\"lexiInteractImgB\" class=\"lexi\"><img src=\"/images/lexiComp/Lexicomp_2012_71x17.gif\" width=\"71\" height=\"17\" border=\"0\"/></div><div class=\"clear\"></div><p style=\"text-indent:0em;display:inline\">There are no known significant interactions.</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F16222944\" class=\"block pri drugH1Div\"><span class=\"drugH1\">Pregnancy Implications</span>\n    <p style=\"text-indent:0em;display:inline\">Adverse effects to the fetus were not observed in animal reproduction studies. Due to the altered immune status of pregnant women, SSPE may be exacerbated during pregnancy and may progress rapidly. Because this condition is rare, use of inosine pranobex in pregnant women is limited to case reports (Cole, 2007)</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F16222983\" class=\"block mop drugH1Div\"><span class=\"drugH1\">Monitoring Parameters</span>\n    <p style=\"text-indent:0em;display:inline\">Uric acid (serum and urine)</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F16222966\" class=\"block pha drugH1Div\"><span class=\"drugH1\">Mechanism of Action</span>\n    <p style=\"text-indent:0em;display:inline\">Exact mechanism has not been fully elucidated; may possess antiviral and immunomodulating effects by potentiating T-lymphocyte and macrophage cell function and by influencing cytokine production (Milano, 1991; Petrova, 2010; Wybran, 1978). </p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F16222968\" class=\"block phk drugH1Div\"><span class=\"drugH1\">Pharmacodynamics/Kinetics</span>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Metabolism: Rapid to uric acid; also undergoes glucuronidation and oxidation</p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Half-life elimination: ~50 minutes (Campoli-Richards, 1986)</p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Time to peak: 1 hour (Campoli-Richards, 1986)</p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Excretion: Urine (as uric acid, glucuronide and oxide metabolites, and unchanged drug)</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F22059524\" class=\"list fbnlist drugH1Div drugBrandNames\"><span class=\"drugH1\">Brand Names: International</span>\n    <ul>\n      <li>Imin (SG);</li>\n      <li>Imunovir (GB, IE, NO, NZ);</li>\n      <li>Isoprinosine (AE, BE, BG, CL, CR, CZ, DE, DO, EG, FR, GR, GT, HN, HR, KW, LT, LU, LV, NI, PA, PH, RO, RU, SK, SV);</li>\n      <li>Isprinol (ID);</li>\n      <li>Izoprynozyn (UA);</li>\n      <li>Laprosin (ID);</li>\n      <li>Neosine (PL);</li>\n      <li>Pranosine (CR, DO, GT, HN, NI, PA, SV);</li>\n      <li>Prinol (ID);</li>\n      <li>Prinosine (KR);</li>\n      <li>Pronovir (ID)</li></ul></div>\r\n</div><div id=\"topicAgreement\">Use of UpToDate is subject to the <a href=\"https://www.uptodate.com/legal/license\" class=\"licenseLink\" id=\"sla_in_page\">Subscription and License Agreement</a>.</div><div id=\"references\" class=\"headingAnchor\"><h1>REFERENCES</h1><ol id=\"reference\">\r\n<li>\r\n<div class=\"reference\">\n    Campoli-Richards, Sorkin EM, and Heel RC, &ldquo;Inosine Pranobex. A Preliminary Review of Its Pharmacodynamic and Pharmacokinetic Properties, and Therapeutic Efficacy,&rdquo; <i>Drugs</i>, 1986, 32(5):383-424.<span class=\"pubmed-id\"> [PubMed <a href=\"https://www.uptodate.com/contents/inosine-pranobex-united-states-not-available-drug-information/abstract-text/2431857/pubmed\" target=\"_blank\" id=\"2431857\">2431857</a>]</span></div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Chang TW and Weinstein L, &ldquo;Antiviral activity of Isoprinosine <i>in vitro</i> and <i>in vivo</i>,&rdquo; <i>Am J Med Sci</i>, 1973, 265(2):143-6. <span class=\"pubmed-id\"> [PubMed <a href=\"https://www.uptodate.com/contents/inosine-pranobex-united-states-not-available-drug-information/abstract-text/4350802/pubmed\" target=\"_blank\" id=\"4350802\">4350802</a>]</span></div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Cole AJ, Henson JW, Roehrl MH, et al, &ldquo;Case Records of the Massachusetts General Hospital. Case 24-2007. A 20-Year-Old Pregnant Woman With Altered Mental Status,&rdquo; <i>N Engl J Med</i>, 2007, Aug 9;357(6):589-600. <span class=\"pubmed-id\"> [PubMed <a href=\"https://www.uptodate.com/contents/inosine-pranobex-united-states-not-available-drug-information/abstract-text/17687135/pubmed\" target=\"_blank\" id=\"17687135\">17687135</a>]</span></div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Milano S, Dieli M, Millott S, et al, &ldquo;Effect of Isoprinosine on IL-2, IFN-&upsih; and IL-4 Production <i>in vivo</i> and <i>in vitro</i>,&rdquo; <i>Int J Immunopharmacol</i>, 1991, 13(7):1013-8.<span class=\"pubmed-id\"> [PubMed <a href=\"https://www.uptodate.com/contents/inosine-pranobex-united-states-not-available-drug-information/abstract-text/1722191/pubmed\" target=\"_blank\" id=\"1722191\">1722191</a>]</span></div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Ohnishi H, Kosuzume H, Inaba H, et al, &ldquo;The Immunomodulatory Action of Inosiplex in Relation to its Effects in Experimental Viral Infections,&rdquo; <i>Int J Immunopharmacol</i>, 1983, 5(3):181-96.<span class=\"pubmed-id\"> [PubMed <a href=\"https://www.uptodate.com/contents/inosine-pranobex-united-states-not-available-drug-information/abstract-text/6194125/pubmed\" target=\"_blank\" id=\"6194125\">6194125</a>]</span></div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Petrova M, Jelev D, Ivanova A, et al, &ldquo;Isoprinosine Affects Serum Cytokine Levels in Healthy Adults,&rdquo; <i>J Interferon Cytokine Res</i>, 2010, 30(4):223-8.<span class=\"pubmed-id\"> [PubMed <a href=\"https://www.uptodate.com/contents/inosine-pranobex-united-states-not-available-drug-information/abstract-text/20038210/pubmed\" target=\"_blank\" id=\"20038210\">20038210</a>]</span></div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Wybran J, Govaerts A, and Appelboom T, &ldquo;Inosiplex, a Stimulating Agent for Normal Human T Cells and Human Leukocytes,&rdquo; <i>J Immunol</i>, 1978, 121(3):1184-7.<span class=\"pubmed-id\"> [PubMed <a href=\"https://www.uptodate.com/contents/inosine-pranobex-united-states-not-available-drug-information/abstract-text/80429/pubmed\" target=\"_blank\" id=\"80429\">80429</a>]</span></div>\r\n</li></ol></div><div id=\"topicVersionRevision\">Topic 88326 Version 37.0</div></div>","outline":"<div id=\"outlineSections\"><h2>Topic Outline</h2><ul><li class=\"plainItem\"><a sectionName=\"Brand Names: Canada\" href=\"#F16144138\" class=\"outlineLink\">Brand Names: Canada</a></li><li class=\"plainItem\"><a sectionName=\"Pharmacologic Category\" href=\"#F16222941\" class=\"outlineLink\">Pharmacologic Category</a></li><li class=\"plainItem\"><a sectionName=\"Dosing: Adult\" href=\"#F16222976\" class=\"outlineLink\">Dosing: Adult</a></li><li class=\"plainItem\"><a sectionName=\"Dosing: Renal Impairment (Adult)\" href=\"#F50990268\" class=\"outlineLink\">Dosing: Renal Impairment (Adult)</a></li><li class=\"plainItem\"><a sectionName=\"Dosing: Hepatic Impairment (Adult)\" href=\"#F50987470\" class=\"outlineLink\">Dosing: Hepatic Impairment (Adult)</a></li><li class=\"plainItem\"><a sectionName=\"Dosing: Pediatric\" href=\"#F16222975\" class=\"outlineLink\">Dosing: Pediatric</a></li><li class=\"plainItem\"><a sectionName=\"Dosing: Renal Impairment (Pediatric)\" href=\"#F51159582\" class=\"outlineLink\">Dosing: Renal Impairment (Pediatric)</a></li><li class=\"plainItem\"><a sectionName=\"Dosing: Hepatic Impairment (Pediatric)\" href=\"#F51159583\" class=\"outlineLink\">Dosing: Hepatic Impairment (Pediatric)</a></li><li class=\"plainItem\"><a sectionName=\"Dosing: Geriatric\" href=\"#F16222977\" class=\"outlineLink\">Dosing: Geriatric</a></li><li class=\"plainItem\"><a sectionName=\"Dosage Forms: Canada\" href=\"#F16222986\" class=\"outlineLink\">Dosage Forms: Canada</a></li><li class=\"plainItem\"><a sectionName=\"Product Availability\" href=\"#F16222985\" class=\"outlineLink\">Product Availability</a></li><li class=\"plainItem\"><a sectionName=\"Administration\" href=\"#F16222980\" class=\"outlineLink\">Administration</a></li><li class=\"plainItem\"><a sectionName=\"Use\" href=\"#F16144139\" class=\"outlineLink\">Use</a></li><li class=\"plainItem\"><a sectionName=\"Adverse Reactions\" href=\"#F16222949\" class=\"outlineLink\">Adverse Reactions</a></li><li class=\"plainItem\"><a sectionName=\"Contraindications\" href=\"#F16222945\" class=\"outlineLink\">Contraindications</a></li><li class=\"plainItem\"><a sectionName=\"Warnings/Precautions\" href=\"#F16222946\" class=\"outlineLink\">Warnings/Precautions</a></li><li class=\"plainItem\"><a sectionName=\"Metabolism/Transport Effects\" href=\"#F16265510\" class=\"outlineLink\">Metabolism/Transport Effects</a></li><li class=\"plainItem\"><a sectionName=\"Drug Interactions\" href=\"#F16265508\" class=\"outlineLink\">Drug Interactions</a></li><li class=\"plainItem\"><a sectionName=\"Pregnancy Implications\" href=\"#F16222944\" class=\"outlineLink\">Pregnancy Implications</a></li><li class=\"plainItem\"><a sectionName=\"Monitoring Parameters\" href=\"#F16222983\" class=\"outlineLink\">Monitoring Parameters</a></li><li class=\"plainItem\"><a sectionName=\"Mechanism of Action\" href=\"#F16222966\" class=\"outlineLink\">Mechanism of Action</a></li><li class=\"plainItem\"><a sectionName=\"Pharmacodynamics/Kinetics\" href=\"#F16222968\" class=\"outlineLink\">Pharmacodynamics/Kinetics</a></li><li class=\"plainItem\"><a sectionName=\"Brand Names: International\" href=\"#F22059524\" class=\"outlineLink\">Brand Names: International</a></li><li class=\"plainItem\"><a href=\"#references\">REFERENCES</a></li></ul></div><div><h2>GRAPHICS <a href=\"#\" id=\"viewAllGraphicsLink\">View All</a></h2><div id=\"outlineGraphics\"><ul><li><div id=\"DRUG_GEN/88326|TAB\" class=\"openRelatedGraphics\"><a href=\"#\" title=\"TABLES\">TABLES</a></div><ul><li><a href=\"image.htm?imageKey=DRUG/57469\" class=\"graphic graphic_table\">- Lexicomp clinical abbreviations</a></li></ul></li></ul></div></div><div><h2>RELATED TOPICS</h2><div id=\"outlineTopics\"><ul><li><a href=\"topic.htm?path=inosine-pranobex-united-states-not-available-patient-drug-information\" class=\"drug drug_patient\">Inosine pranobex (United States: Not available): Patient drug information</a></li></ul></div></div>","javascript":null}